The Coca-Cola Company has recalled some Sprite, Fanta, and Diet Coke batches. The beverage manufacturer takes about 2,000 cases of the said drinks off the market shelves.
As per NBC News, the U.S. Food and Drug Administration (FDA) announced the recall through a filing. While this event was only publicized this week, the food and drug authority said the call back of Coca-Cola’s Sprite, Diet Coke, and Fanta actually started last month.
Reason for the Recall and Affected Products
The FDA revealed that Coca-Cola’s latest beverage recall involves 1,557 cases of Sprite in 12-ounce cans with the Best By date of 07/29/24, 417 cases of Diet Coke (Best By 01/29/24), and 14 cases of Fanta Orange (Best By 07/29/24). The particular batches affected by the recall were said to have been manufactured by United Packers, which is located in Alabama.
The recalled drinks were distributed in three states: Florida, Alabama, and Mississippi. The main reason for the recall is the potential presence of foreign material in the canned drinks. Coca-Cola said no other products besides the three mentioned brands and batches are affected.
Update on the Recall
In a statement that Coca-Cola’s representative shared with PEOPLE, the company has completed all the recall activities in the affected market. Then again, the “foreign material” type found in the soft drinks was not specified in the reports.
Meanwhile, Today reported that this is not the first time Coca-Cola issued a recall for the same reason of possible “foreign material” contamination. In 2021, the beverage maker recalled several variants of its Minute Maid juice products because some foreign metal objects were suspected to have tainted the drinks. At that time, about 7,000 cases of the voluntarily recalled juice were classified by the FDA as Class II recall.
Photo by: Senad Palic/Unsplash


BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 



